Clinical Trials Browser

Withdrawn × ADI PEG20 × Clear all

NCT06006286 2024-08-26

A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma

Phase 1/2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular

NCT04965714 2023-02-16

Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer

Phase 2 Withdrawn

Gastrointestinal

Resectable Hepatocellular Carcinoma

NCT03498222 2020-02-25

iTRAP

Phase 1 Withdrawn

Carcinoma, Non-Small-Cell Lung